
We reported financial results for the third quarter, highlighting recent progress and business updates, including the completion of enrollment in our Phase 2 HORIZON trial in #AMKD and continued advancement of our MZE782 program in #PKU and #CKD. Read the full announcement here: ir.mazetx.com/news-releases/…























